Mid-term report 2013 - The European LeukemiaNet

European LeukemiaNet Midterm Report, 08-RNP-071
7.6.4 Scientific publications
Author(s)
Abdel-Wahab O, Pardanani A, Bernard OA,
Finazzi G, Crispino JD, Gisslinger H, Kralovics
R, Odenike O, Bhalla K, Gupta V, Barosi G,
Gotlib J, Guglielmelli P, Kiladjian JJ, Noel P,
Title
Unraveling the genetic underpinnings of
myeloproliferative neoplasms and
understanding their effect on disease
Type of
Publication
Cazzola M, Vannucchi AM, Hoffman R, Barbui course and response to therapy:
T, Thiele J, Van Etten RA, Mughal T, Tefferi
A.
proceedings from the 6th International
Post-ASH Symposium. article Am J Hematol.
ECIL-3 classical diagnostic procedures for
the diagnosis of invasive fungal diseases
Bone Marrow
Arendrup MC, Bille J, Dannaoui E, Ruhnke M, Heussel in patients CP, with Kibbler leukaemia. C
article
Transplant.
Barbui T, Barosi G, Birgegard G, Cervantes F,
Finazzi G, Griesshammer M, Harrison C,
Hasselbalch HC, Hehlmann R, Hoffman R, Philadelphia-negative classical
Kiladjian JJ, Kröger N, Mesa R, McMullin MF, myeloproliferative neoplasms: critical
Pardanani A, Passamonti F, Vannucchi AM, concepts and management
Reiter A, Silver RT, Verstovsek S, Tefferi A; recommendations from European
European LeukemiaNet.
LeukemiaNet. article J Clin Oncol.
If Other,
specify In (journal title…) Volume, pages, year…
Peer-reviewed
ESF acknow-ledged
Open Access (OA)
If OA,
enter
web
address
Funde
d by
ELN
Recomm Meeti
endation ESF ng
Pubme
d
recher
che
2012 May;87(5):562-8. doi:
10.1002/ajh.23169. Epub 2012
Mar 28.
x
2012 Aug;47(8):1030-45. doi:
10.1038/bmt.2011.246. Epub
2012 Jan 9. x x
2011 Feb 20;29(6):761-70. doi:
10.1200/JCO.2010.31.8436.
Epub 2011 Jan 4. x x
Barbui T, Thiele J, Passamonti F, Rumi E,
Boveri E, Ruggeri M, Rodeghiero F, d'Amore Survival and disease progression in
ES, Randi ML, Bertozzi I, Marino F, Vannucchi essential thrombocythemia are
AM, Antonioli E, Carrai V, Gisslinger H,
Buxhofer-Ausch V, Müllauer L, Carobbio A,
Gianatti A, Gangat N, Hanson CA, Tefferi A.
significantly influenced by accurate
morphologic diagnosis: an international
study. article J Clin Oncol.
2011 Aug 10;29(23):3179-84.
doi:
10.1200/JCO.2010.34.5298.
Epub 2011 Jul 11.
x
Barosi G, Birgegard G, Finazzi G,
A unified definition of clinical resistance
Griesshammer M, Harrison C, Hasselbalch H, and intolerance to hydroxycarbamide in
Kiladijan JJ, Lengfelder E, Mesa R, Mc Mullin polycythaemia vera and primary
MF, Passamonti F, Reilly JT, Vannucchi AM,
Barbui T.
myelofibrosis: results of a European
LeukemiaNet (ELN) consensus process. article Br J Haematol.
Barosi G, Mesa R, Finazzi G, Harrison C,
Kiladjian JJ, Lengfelder E, Mc Mullin MF,
Passamonti F, Vannucchi AM, Besses C, Revised response criteria for
Gisslinger H, Samuelsson J, Verstovsek S, polycythemia vera and essential
Hoffman R, Pardanani A, Cervantes F, Tefferi thrombocythemia: a ELN and IWG-MRT
A, Barbui T.
consensus project. article Blood.
Barosi G, Tefferi A, Barbui T; ad hoc
committee ‘Definition of clinically relevant Do current response criteria in classical
outcomes for contemporarily clinical trials in Ph-negative myeloproliferative
Ph-neg MPNs’.
neoplasms capture benefit for patients? article
Leukemia.
Béné MC, Nebe T, Bettelheim P, Buldini B,
Bumbea H, Kern W, Lacombe F, Lemez P,
Marinov I, Matutes E, Maynadié M,
Oelschlagel U, Orfao A, Schabath R,
Solenthaler M, Tschurtschenthaler G,
Vladareanu AM, Zini G, Faure GC, Porwit A.
Immunophenotyping of acute leukemia
and lymphoproliferative disorders: a
consensus proposal of the European
LeukemiaNet Work Package 10. review Leukemia.
Therapeutic drug monitoring of imatinib
Bouchet S, Titier K, Moore N, Lassalle R, in chronic myeloid leukemia:
Ambrosino B, Poulette S, Schuld P, Belanger experience from 1216 patients at a
C, Mahon FX, Molimard M.
centralized laboratory.
Buechner, Thomas; Schlenk, Richard F.;
Schaich, Markus; et al.
Carobbio, Alessandra; Finazzi, Guido;
Antonioli, Elisabetta; et al.
article
Acute Myeloid Leukemia (AML):
Different Treatment Strategies Versus a
Common Standard Arm-Combined
Prospective Analysis by the German
AML Intergroup
article
Fundam Clin
Pharmacol.
Hydroxyurea in essential
thrombocythemia: rate and clinical
relevance of responses by European
LeukemiaNet criteria article BLOOD
ECIL 3-2009 update guidelines for
Castagna L, Bramanti S, Sarina B, Todisco E, Ibatici antifungal A, Santoro management. A.
Castagnetti, Fausto; Testoni, Nicoletta;
Luatti, Simona; et al.
Deletions of the Derivative
Chromosome 9 Do Not Influence the
Response and the Outcome of Chronic
Myeloid Leukemia in Early Chronic
Phase Treated With Imatinib Mesylate:
GIMEMA CML Working Party Analysis
article
article
JOURNAL OF CLINICAL
ONCOLOGY
Bone Marrow
Transplant.
JOURNAL OF CLINICAL
ONCOLOGY
The European LeukemiaNet AML
Cornelissen JJ, Gratwohl A, Schlenk RF,
Sierra J, Bornhäuser M, Juliusson G, Råcil Z,
Working Party consensus statement on
allogeneic HSCT for patients with AML in
Rowe JM, Russell N, Mohty M, Löwenberg B, remission: an integrated-risk adapted
Socié G, Niederwieser D, Ossenkoppele GJ. approach. review Nat Rev Clin Oncol.
Cross, N. C. P.; White, H. E.; Mueller, M. C.;
et al.
Della Porta et al.,
2010 Mar;148(6):961-3. doi:
10.1111/j.1365-
2141.2009.08019.x. Epub 2009
Nov 23. x x
2013 Apr 16. [Epub ahead of
print] x x
2012 May;26(5):1148-9. doi:
10.1038/leu.2011.337. Epub
2011 Nov 22. No abstract
available.
x
2011 Apr;25(4):567-74. doi:
10.1038/leu.2010.312. Epub
2011 Jan 21. Review. x x
2012 Oct 31. doi:
10.1111/fcp.12007. [Epub
ahead of print]
Volume: 30 Issue: 29 Pages:
3604-3610 DOI:
10.1200/JCO.2012.42.2907
Published: OCT 10 2012
Volume: 116 Issue: 7 Pages:
1051-1055 DOI:
10.1182/blood-2010-03-
272179 Published: AUG 19
2010 x
2012 Jun;47(6):866. doi:
10.1038/bmt.2011.154. Epub
2011 Aug 8. x x
Volume: 28 Issue: 16 Pages:
2748-2754 DOI:
10.1200/JCO.2009.26.7963
Published: JUN 1 2010
2012 Oct;9(10):579-90. doi:
10.1038/nrclinonc.2012.150.
Epub 2012 Sep 4. Review. x x
Volume: 26 Issue: 10 Pages:
2172-2175 DOI:
10.1038/leu.2012.104
Published: OCT 2012 x x
Standardized definitions of molecular
response in chronic myeloid leukemia review LEUKEMIA
Multicentre validation of a reproducible
flow cytometric score for the diagnosis
of low-risk myelodysplastic syndromes:
results of a European LeukemiaNET
study. article Haematologica.. 2012 Aug;97(8):1209-17 x
x
x
x
Deschler, Barbara; Ihorst, Gabriele;
Platzbecker, Uwe; et al.
Parameters detected by geriatric and
quality of life assessment in 195 older
patients with myelodysplastic
syndromes and acute myeloid leukemia
are highly predictive for outcome article HAEMATOLOGICA
Volume: 98 Issue: 2 Pages:
208-216 DOI:
10.3324/haematol.2012.06789
2 Published: FEB 2013 x
28